Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Cardiovascular disease remains the leading cause of death in women. Given accumulating evidence on sex- and gender-based differences in cardiovascular disease development and outcomes, the need for more effective approaches to screening for risk factors and phenotypes in women is ever urgent. Public health surveillance and health care delivery systems now continuously generate massive amounts of data that could be leveraged to enable both screening of cardiovascular risk and implementation of tailored preventive interventions across a woman’s life span. However, health care providers, clinical guidelines committees, and health policy experts are not yet sufficiently equipped to optimize the collection of data on women, use or interpret these data, or develop approaches to targeting interventions. Therefore, we provide a broad overview of the key opportunities for cardiovascular screening in women while highlighting the potential applications of artificial intelligence along with digital technologies and tools.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dissecting racial bias in an algorithm used to manage the health of populations
Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019) · Science · doi:10.1126/science.aax2342 · Cited by 7,137 · cited 1×
“49 This algorithm was trained to predict health care costs and not actual illness.”
MethodGrundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Making Neighborhood-Disadvantage Metrics Accessible — The Neighborhood Atlas
Kind, A. J. H., & Buckingham, W. R. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1802313 · Cited by 3,310
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908655 · Cited by 2,430
Christodoulou, E., Ma, J., Collins, G. S., Steyerberg, E. W., Verbakel, J. Y., & Van Calster, B. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.02.004 · Cited by 2,119 · cited 1×
“27,28 This leaves a few unanswered questions for whether modern ML approaches are necessary, and which, if any, advantages do they provide.”
BackgroundLarge-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., Balasubramanian, V., Russo, A. M., Rajmane, A., Cheung, L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901183 · Cited by 1,917
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.002 · Cited by 1,751
Attia, Z. I., Noseworthy, P. A., Lopez-Jimenez, F., Asirvatham, S. J., Deshmukh, A. J., Gersh, B. J., Carter, R. E., Yao, X., Rabinstein, A. A., Erickson, B. J., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31721-0 · Cited by 1,613 · cited 1×
“34 The left ventricular dysfunction algorithm has been reevaluated and validated in clinical 35 and nonclinical 36 settings and in racial and ethnic subgroups 37 and has been found to be associated with improved detection of left ventricular dysfunction in a pragmatic clinical trial.”
MethodSelf-citationAttia, Z. I., Kapa, S., Lopez-Jimenez, F., McKie, P. M., Ladewig, D. J., Satam, G., Pellikka, P. A., Enriquez-Sarano, M., Noseworthy, P. A., Munger, T. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0240-2 · Cited by 1,389 · cited 1×
“These include the detection of left ventricular dysfunction, 30 hypertrophic cardiomyopathy, 31 cardiac amyloidosis, 32 aortic stenosis, 33 and interestingly, detection of silent atrial fibrillation from an ECG showing normal sinus rhythm.”
BackgroundSelf-citation
Cited by
Wang, Y., Liu, C., Hu, W., Luo, L., Shi, D., Zhang, J., Yin, Q., Zhang, L., Han, X., & He, M. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01032-9 · Cited by 76
Artificial intelligence bias in the prediction and detection of cardiovascular disease
Mihan, A., Pandey, A., & Van Spall, H. G. C. (2024) · npj Cardiovascular Health · doi:10.1038/s44325-024-00031-9 · Cited by 51
Ajayi, K. V., Wachira, E., Onyeaka, H. K., Montour, T., Olowolaju, S., & Garney, W. (2022) · JMIR mHealth and uHealth · doi:10.2196/39520 · Cited by 34
“In their review, Adedinsewo and colleagues [11] succinctly outlined how artificial intelligence and digital health tools can be leveraged to improve the screening, monitoring, educating, and managing of chronic conditions among women during the life course.”
BackgroundInfluentialZhang, A., Pyon, R. E., Chen, K., & Lin, A. Y. (2023) · FACE · doi:10.1177/27325016231187985 · Cited by 16
“38-40 Despite the advantages of artificial intelligence and machine learning, the use of AI and ML to assess hypernasality is relatively new.”
Background
Metadata
- Authors
- Adedinsewo, D. A., Pollak, A. W., Phillips, S. D., Smith, T. L., Svatikova, A., Hayes, S. N., Mulvagh, S. L., Norris, C., Roger, V. L., Noseworthy, P. A., Yao, X., & Carter, R. E.
- Venue
- Circulation Research
- Published
- 2022-02-18
- Volume
- 130
- Issue
- 4
- Pages
- 673-690
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W4212842985
- Cited by
- 85
- References
- 39
- FWCI
- 13.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools. https://app.cochat.ai/papers/10.1161/circresaha.121.319876
- The paper
- Adedinsewo, D. A., Pollak, A. W., Phillips, S. D., Smith, T. L., Svatikova, A., Hayes, S. N., Mulvagh, S. L., Norris, C., Roger, V. L., Noseworthy, P. A., Yao, X., & Carter, R. E. (2022). Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools. Circulation Research. https://doi.org/10.1161/circresaha.121.319876
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.